Earnings (loss) per Share

12 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

22. Earnings (loss) per Share

 

The following table sets forth the computation of basic and diluted income (loss) attributable to shareholders of Sinovac per share:

	For the year ended December 31
	2016		2015		2014
			(Restated)		(Restated)
Numerator
Income (loss) from continuing operations		(3,058)		(229)		279
Less: Income (loss) attributable to non-controlling interests		(124)		459		270
Income (loss) attributable to shareholders of Sinovac from continuing operations		(2,934)		(688)		9
Income (loss) attributable to shareholders of Sinovac from discontinued operations		2,338		(728)		(1,524)
Net loss attributable to shareholders of Sinovac		(596)		(1,416)		(1,515)
Denominator
Basic weighted average number of common shares outstanding		56,949,083		56,313,927		55,681,076
Dilutive effect of stock options		-		-		433,126
Diluted weighted average number of common shares outstanding		56,949,083		56,313,927		56,114,202
Basic net income (loss) per share
Continuing operations		(0.05)		(0.02)		0.00
Discontinued operations		0.04		(0.01)		(0.03)
Basic net income (loss) per share		(0.01)		(0.03)		(0.03)
Diluted net income (loss) per share
Continuing operations		(0.05)		(0.02)		0.00
Discontinued operations		0.04		(0.01)		(0.03)
Diluted net income (loss) per share		(0.01)		(0.03)		(0.03)

Anti-dilutive options and non-vested restricted shares were not included in the diluted EPS calculation for the year ended December 31, 2016.